Milestone Pharmaceuticals Stock Price on October 16, 2024
| MIST Stock | USD 1.99 0.12 6.42% |
Below is the normalized historical share price chart for Milestone Pharmaceuticals extending back to May 09, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Milestone Pharmaceuticals stands at 1.99, as last reported on the 2nd of December, with the highest price reaching 2.00 and the lowest price hitting 1.90 during the day.
If you're considering investing in Milestone Stock, it is important to understand the factors that can impact its price. Milestone Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Milestone Pharmaceuticals has Sharpe Ratio of 0.2, which conveys that the firm had a 0.2% return per unit of risk over the last 3 months. By analyzing Milestone Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.6% is justified by implied risk. Please exercise Milestone Pharmaceuticals' Risk Adjusted Performance of 0.1414, downside deviation of 2.19, and Mean Deviation of 1.94 to check out if our risk estimates are consistent with your expectations.
At this time, Milestone Pharmaceuticals' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 35.5 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 34.5 M in 2024. . At this time, Milestone Pharmaceuticals' Price To Sales Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 4.49 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (1.62) in 2024. Milestone Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of May 2019 | 200 Day MA 1.5663 | 50 Day MA 1.6109 | Beta 1.729 |
Milestone |
Sharpe Ratio = 0.2019
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MIST | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.0 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.6 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Milestone Pharmaceuticals is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Milestone Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 4.4196 | Enterprise Value Ebitda (1.43) | Price Sales 91.9492 | Shares Float 52.8 M | Wall Street Target Price 10.25 |
Related Headline
Lyra Therapeutics Headline on 16th of October 2024
Acquisition by Jason Cavalier of 100000 shares of Lyra Thera... by Jason Cavalier
Filed transaction by Lyra Therapeutics Officer: Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Milestone Pharmaceuticals Valuation on October 16, 2024
It is possible to determine the worth of Milestone Pharmaceuticals on a given historical date. On October 16, 2024 Milestone was worth 1.47 at the beginning of the trading date compared to the closed value of 1.46. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Milestone Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Milestone Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Milestone Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Milestone Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.52 | 1.52 | 1.43 | 1.49 | 119,116 | |
10/16/2024 | 1.47 | 1.52 | 1.44 | 1.46 | 157,331 |
| 1.48 | 1.52 | 1.44 | 1.47 | 139,848 |
| Backtest Milestone Pharmaceuticals | | | Milestone Pharmaceuticals History | | | Milestone Pharmaceuticals Valuation | Previous | Next |
Milestone Pharmaceuticals Trading Date Momentum on October 16, 2024
| On October 17 2024 Milestone Pharmaceuticals was traded for 1.47 at the closing time. The top price for the day was 1.52 and the lowest listed price was 1.44 . The trading volume for the day was 139.8 K. The trading history from October 17, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 0.68% . The trading delta at closing time against the current closing price is 0.00% . |
Milestone Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Milestone Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Milestone Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Milestone financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Milestone Pharmaceuticals Stock history
Milestone Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Milestone is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Milestone Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Milestone Pharmaceuticals stock prices may prove useful in developing a viable investing in Milestone Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 43 M | 34.5 M | |
| Net Loss | -52.5 M | -55.2 M |
Milestone Pharmaceuticals Quarterly Net Working Capital |
|
Milestone Pharmaceuticals Stock Technical Analysis
Milestone Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Milestone Pharmaceuticals Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Milestone Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Milestone Pharmaceuticals December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Milestone Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Milestone Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Milestone Pharmaceuticals stock market strength indicators, traders can identify Milestone Pharmaceuticals entry and exit signals to maximize returns
Milestone Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Milestone Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Milestone Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Milestone to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1414 | |||
| Jensen Alpha | 0.3142 | |||
| Total Risk Alpha | 0.0147 | |||
| Sortino Ratio | 0.176 | |||
| Treynor Ratio | 0.3292 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Milestone Stock Analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.